Clinical Trial Update: Paclitaxel Polymeric Micelles and Carboplatin in Combination With Iparomilimab and Tuvonralimab Neoadjuvant Therapy for Triple-negative Breast Cancer [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update describes a neoadjuvant regimen for triple-negative breast cancer using paclitaxel polymeric micelles and carboplatin in combination wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Iparomilimab (iparomilimab)
• Paclitaxel polymeric micelles (paclitaxel)
• Tuvonralimab (tuvonralimab)

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Triple-Negative Breast Cancer (TNBC), Neoadjuvant Therapy | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING